CLOs on the Move

Motus GI

www.motusgi.com

 
Motus GI Holdings, Inc. (NASDAQ: MOTS) is a medical technology company based in the U.S., with subsidiaries in the U.S. and Israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The Company is focused on the development and commercialization of the Pure-Vu® System, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.motusgi.com
  • 1301 E. Broward Blvd. Suite 310
    Fort Lauderdale, FL USA 33301
  • Phone: 954.541.8000

Executives

Name Title Contact Details

Similar Companies

Golden Helix

Golden Helix is a Bozeman, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

A-T Surgical Mfg. Co.

A-T Surgical is one of America's oldest independent manufacturers of quality orthopedic soft goods including products for neck, arm, elbow, wrist, hand, back, leg, knee ankle, and also supports such as trusses, abdominal, maternity and rib. A-T

Ophthalmic Imaging Systems

Ophthalmic Imaging Systems is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ArthroSurface

ArthroSurface is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Franklin, MA. To find more information about ArthroSurface, please visit www.arthrosurface.com

Dthera

Dthera™ Sciences (OTCQB:DTHR) is the leading digital therapeutic company focusing on the elderly. The San Diego-based, publicly traded company is working to improve the lives of seniors and individuals suffering from neurodegenerative diseases, as well as those who care for them. It has two core products: ReminX™, a commercially available consumer health product for individuals suffering from social isolation and dementia; and DTHR-ALZ, and a development-stage product that has been granted Breakthrough Device designation by the FDA for the mitigation of the symptoms of agitation and depression associated with Alzheimer`s disease.